This brand name is authorized in Estonia, Netherlands
The drug VARIQUIN contains one active pharmaceutical ingredient (API):
|
1
Human varicela zoster immunoglobulin
UNII 33T61IWL27 - HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
|
|
Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J06BB03 | Varicella/zoster immunoglobulin | J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1669103 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13946269 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 42463 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
